一个强化学习 (RL) 激发的模拟框架,用于评估万科米辛剂量策略
Bingyu Mao1, Ziqian Xie1, Laila Rasmy1
1McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, United States.
AMIA ... Annual Symposium proceedings. AMIA Symposium
|February 23, 2026
概括
优化万科米辛剂量对于患者的治疗结果至关重要. 使用深度学习和强化学习 (RL) 的新模拟框架有助于确定万科米辛治疗的最佳剂量策略.
科学领域:
- 药理动力学和药理动力学
- 计算生物学 计算生物学
- 机器学习在医学中的应用
背景情况:
- 达到和维持治疗性万科米辛水平对于治疗疗效和尽量减少毒性至关重要.
- 对于万科米剂量的现有指导方针是基于经验数据的,但在各种条件下最优的理论策略尚未完全理解.
研究的目的:
- 开发一种基于强化学习 (RL) 的新型模拟框架,以优化万科米辛剂量策略.
- 将临床指南整合到RL奖励系统中,使用时间度曲线 (AUC) 下的面积.
主要方法:
- 开发了一种深度学习的两部制药动力学模型 (PK-RNN-2CM).
- 利用患者特定的数据生成基准真相时间度曲线.
- 在各种条件下模拟范胺剂量策略,包括噪音干扰,以模拟现实世界的变化.
- 使用24小时AUC和根平均平方误差 (RMSE) 作为评估指标.
主要成果:
- 低剂量和高剂量AUC目标在无噪声模拟中表现相似.
- 低剂量策略在噪音条件下实现了更高的AUC奖励得分.
- 高剂量策略在噪音条件下表现出更大的稳定性.
结论:
- 开发的基于RL的模拟框架为优化万科米辛剂量提供了一种新的方法.
- 这种方法可以帮助改进剂量策略,以改善患者在万科米辛治疗中的结果.
- 该框架能够结合临床指导方针并模拟现实世界的变异性,为治疗药物监测提供了宝贵的见解.
相关概念视频
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
284
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
284
01:20Estimation of k and VD of Aminoglycosides
274
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
274
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
288
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
288
01:28Dosage Regimens: Designs and Approaches
386
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
386
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
261
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
261
01:09One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
963
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
963